Abstract
Early diagnosis for metabolic encephalopathy caused by inborn errors of metabolism is very important for the initiation of early treatment and also for prevention of sequela. Metabolic encephalopathy in the form of seizures can result from many inborn errors of metabolism and considering the large number of disorders causing metabolic encephalopathy, enzyme assays or conventional molecular tests are expensive and take considerably long period of time which results in delayed treatment. In our center we have used next generation DNA sequencing technology as an initial diagnostic test to look for about 700 disorders at the same time for the etiologic diagnosis of a 4-month-old female infant suffering from intractable seizures. The patient was found to have glycine encephalopathy resulting from a previously defined mutation in the GLDC gene. The diagnostic result was obtained much sooner than other conventional investigations. Up to our knowledge, this would be the first case with glycine encephalopathy in the literature who was approached by this novel panel method initially. Although currently, classical evaluation methods such as physical examination, biochemical and conventional molecular investigations are still accepted as the gold standards to clarify the etiology of the metabolic encephalopathy it is obvious that next generation sequence analysis will play a very significant role in the future.
References
Alfadhel M, Al-Thihli K, Moubayed H et al (2013) Drug treatment of inborn errors of metabolism: a systematic review. Arch Dis Child 98:454–461
Haliloğlu G, Vezir E, Baydar L et al (2012) When do we need to perform a diagnostic lumbar puncture for neurometabolic diseases? Positive yield and retrospective analysis from a tertiary center. Turk J Pediatr 54:52–58
Katsanis SH, Katsanis N (2013) Molecular genetic testing and the future of clinical genomics. Nat Rev Genet 14:415–426
Lamperti C, Fang M, Invernizzi F et al (2012) A novel homozygous mutation in SUCLA2 gene identified by exome sequencing. Mol Genet Metab 107:403–408
Merriman B, Ion Torrent R&D Team, Rothberg JM (2012) Progress in ion torrent semiconductor chip based sequencing. Electrophoresis 33:3397–3417
Rahman S, Footitt EJ, Varadkar S et al (2013) Inborn errors of metabolism causing epilepsy. Dev Med Child Neurol 55:23–36
Robinson JT, Thorvaldsdóttir H, Winckler W, Guttman M, Lander ES, Getz G, Mesirov JP (2011) Integrative genomics viewer. Nat Biotechnol 29:24–26
Scala I, Parenti G, Andria G (2012) Universal screening for inherited metabolic diseases in the neonate (and the fetus) (2012). J Matern Fetal Neonatal Med 25(Suppl 5):4–6
Schrader KA, Heravi-Moussavi A, Waters PJ, Senz J, Whelan J, Ha G, Eydoux P, Nielsen T, Gallagher B, Oloumi A, Boyd N, Fernandez BA, Young TL, Jones SJ, Hirst M, Shah SP, Marra MA, Green J, Huntsman DG (2011) Using next-generation sequencing for the diagnosis of rare disorders: a family with retinitis pigmentosa and skeletal abnormalities. J Pathol 225:12–18
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Supplementary Table 1
The list of variants detected in the patient. (XLS 159 kb)
Rights and permissions
About this article
Cite this article
Ezgu, F., Çiftci, B., Topçu, B. et al. Diagnosis of glycine encephalopathy in a pediatric patient by detection of a GLDC mutation during initial next generation DNA sequencing. Metab Brain Dis 29, 211–213 (2014). https://doi.org/10.1007/s11011-014-9482-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-014-9482-y